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SUMMARY 33 
Current estimates of tuberculosis disease burden and cause-specific mortality in HIV-positive people rely 34 
heavily on indirect methods, which are less reliable for ascertaining individual-level causes of death, and 35 
mathematical models.  Minimally-invasive autopsy (MIA) is useful for diagnosing infectious diseases, 36 
provides a reasonable proxy for the gold standard in cause of death ascertainment (complete diagnostic 37 
autopsy) and, used routinely, could improve cause-specific mortality estimates.  From our experiences 38 
performing MIAs in HIV-positive adults in private mortuaries in South Africa (during the Lesedi Kamoso 39 
study), we describe the challenges we faced and make recommendations for the conduct of MIA in future 40 
studies or surveillance programmes, including strategies for effective communication, approaches to 41 
obtaining informed consent, risk management for staff, and efficient preparation for the procedure. 42 
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SETTING 45 
Tuberculosis (TB) is likely the leading cause of death (CoD) in HIV-positive people and is often under-46 
recognised as a cause of morbidity.1  Estimating TB mortality is challenging: current estimates depend 47 
heavily on death certificates, which are often inaccurate in HIV-positive people;2 verbal autopsy, which 48 
differentiates poorly between TB and other HIV-associated CoD;3 and mathematical modelling.4  Complete 49 
diagnostic autopsy is the gold standard for determining CoD, but rates are declining worldwide;5 minimally-50 
invasive autopsy (MIA), however, performs well in diagnosing infectious disease6 and is faster, technically 51 
easier, more portable, probably cheaper, and more acceptable to individuals and families.7  Most autopsy 52 
studies have included only individuals dying in health facilities1 and are poorly representative of most high 53 
TB burden countries, where many deaths occur in the community.   54 
A community-based MIA surveillance programme at sentinel sites would improve quantification of disease 55 
burden and mortality estimates, but any such venture would encounter many challenges.  From mid-2013 to 56 
late 2016, we conducted an MIA study in South Africa (Lesedi Kamoso [“light for the future”]) to estimate 1) 57 
the autopsy prevalence of TB and other infections8 and 2) CoD9 in HIV-positive adults who died after 58 
enrolment into a trial of empirical TB treatment (“TB Fast Track”).10  Based on our experiences conducting 59 
MIAs in private mortuaries and using information collated from field notes and discussions with the research 60 
team, we describe how challenges were overcome and provide guidance for those planning similar studies 61 
or considering incorporating MIA into surveillance programmes.  We do not discuss technicalities of the MIA 62 
procedure, as detailed guidance has been published by other groups.11,12  The parent and sub-study received 63 
ethical approval from the research ethics committees of The University of the Witwatersrand, the London 64 
School of Hygiene & Tropical Medicine, and local health authorities. 65 
ASPECTS OF INTEREST 66 
Preparation 67 
Three to six months before data collection begins, the proposed autopsy activity should be discussed with 68 
local stakeholders (Figure 1), including community, traditional, and religious leaders; the police; patient 69 
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advocates; mortuary owners; managers of local clinics and hospitals; and, ideally, a representative of the 70 
Department of Health.  We suggest providing a plain-language written summary, in local languages, with 71 
contact details of key personnel and oversight bodies.  Meetings should be held at regular intervals for the 72 
duration of the programme, allowing for findings to be shared and for stakeholders to discuss concerns.   73 
Ideally, this preparation period should also include formative work, conducted by social scientists, to gain a 74 
deeper understanding of the dynamics within the community, burial and cremation practices, and beliefs 75 
around death, dying, and autopsy.  The scope of religious beliefs and practices should also be explored.  76 
Information collected during the formative work should inform the design of participant information sheets, 77 
the routes by which participants and families are approached, and the training of staff in obtaining consent 78 
and counselling individuals and families. 79 
Death notification 80 
We were largely reliant on family members informing clinic-based research staff of the death of a 81 
participant.  On most occasions (229 [79%] of 289 deaths), notification occurred after burial and an autopsy 82 
could not be completed.  We observed that the likelihood of timely notification depended on the trust 83 
between the clinic-based researcher and the participant/their family: researchers were more likely to be 84 
informed in time if they were seen as supportive and understanding, and particularly if they were regularly 85 
‘checking in’ (sometimes informally) on the health of the participant. 86 
Informed consent 87 
Whenever possible, we requested consent for MIA from participants at enrolment to the parent trial: of 88 
2,200 participants asked, 1,675 (76%) agreed; participants were not offered a financial incentive for 89 
participation.  We approached the family for permission to proceed if the decedent had consented to MIA at 90 
enrolment or for written consent if the decedent had not been asked (the MIA sub-study was initiated some 91 
months after the start of the parent study and therefore some participants were not asked to consent to 92 
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MIA at enrolment).  If a decedent had declined to consent at enrolment, the family was not approached.  Of 93 
43 families approached, 36 (84%) gave consent for MIA.   94 
We developed consent procedures after discussion with clinical research experts in South Africa, including 95 
those previously involved in autopsy studies.  It should be noted that these procedures were considered 96 
suitable for a study involving adults only; studies or programmes that involve children will entail different 97 
considerations and consent processes should be formulated after consultation with relevant experts.  98 
Investigators must be familiar with local legislation around human tissue research, adhere to informed 99 
consent guidelines published by professional and regulatory bodies, and are advised to consult local experts 100 
and institutional review boards.  The recommendations below are intended to improve communication 101 
during the consent-taking process (a common reason for initial refusal of consent in our study was 102 
misunderstanding of the purpose of autopsy; for example, we were frequently asked to justify the need for 103 
further examination when the person had already died).  As in all health research, participants or families 104 
giving consent should be allowed to make an informed decision about their own or their relative’s 105 
participation and all parties must be made aware that they are free to decline or withdraw consent at any 106 
point without risk of immediate or deferred consequences.   107 
The experiences of staff and our fieldnotes suggest that individuals enrolled into the parent study were more 108 
likely to consent to MIA if a researcher could discuss MIA in an open and transparent manner; had a good 109 
understanding of the purpose of autopsy in a research context; and was willing to discuss broader topics, 110 
such as life after death.  An individual consenting to MIA for themselves was also made more likely by the 111 
involvement of a family member in the consent process, availability of additional plain-language written 112 
information, and availability of a staff member for follow-up conversations (some individuals came back to 113 
give consent for MIA at a later date, or simply wanted to continue the conversation with the researcher). 114 
The process for getting consent or permission from the family of a deceased individual may be complicated 115 
by pre-existing tensions within the family; we found it helpful to make our discussions as inclusive as 116 
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possible and took particular care to communicate with senior family members.  On some occasions we had 117 
to make two or three visits to a household before a final decision was made.  Families were not offered a 118 
financial incentive for participation, though they were often (informally) assisted with transport to and from 119 
the mortuary on the day of the MIA.  Among families who gave permission, we observed that decision-120 
making family members understood the MIA procedure and the purpose of the study; the discussion took 121 
place some days before the funeral, with reassurance that MIA would not delay proceedings; and, most 122 
importantly, the researcher(s) had a good understanding of the relevant cultural norms and were able to 123 
listen, empathise, and give families space and time for discussion.   124 
To our surprise, on more than one occasion a family member requested to observe the autopsy and 125 
reported afterwards that they found it a positive experience; however, this was not the norm, and 126 
acceptability of this practice may be very different in other settings, depending on local expectations and 127 
beliefs, underpinning the need for a robust understanding of the context in which MIAs are to be conducted. 128 
In addition, almost all individuals enrolled into our study were from a Christian background, and the funeral 129 
often did not take place for a week or more after death, giving us time to obtain permission and complete 130 
the MIA.  This too may be very different in other settings, and may result in a smaller window in which the 131 
MIA can be conducted; the success of an MIA programme in such settings is likely to depend on the 132 
existence of a strong death notification system, ideally one integrated into hospitals. 133 
Interactions with hospitals and mortuaries 134 
Many private mortuaries in South Africa have informal agreements with hospital staff to facilitate the rapid 135 
transfer of the deceased from hospital to mortuary; often these are well-established networks with financial 136 
implications for those involved.  Our experiences suggest that attempts to conduct MIAs in hospitals are 137 
unlikely to succeed unless clear instructions are issued and enforced by senior hospital management or 138 
unless the MIA programme is integrated into hospital procedures.   139 
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In our study, all MIAs were conducted in private mortuaries; most mortuary staff were helpful and 140 
welcoming, though we did encounter some opposition: twice we were unable to complete the MIA.  As 141 
described above and in Figure 1, early engagement with mortuary managers, with opportunities for 142 
questions and clarification, would have made these interactions considerably easier; however, our study was 143 
conducted over a wide geographical area that included several hundred mortuaries, and we were not able to 144 
do this.  On the day of the MIA, we advise that, if possible, researchers travel to the mortuary accompanied 145 
by a senior family member to facilitate direct communication between the family and mortuary staff.  146 
Providing mortuaries with written information and contact details of study personnel helped establish trust 147 
and made future interactions considerably easier; over the course of the study, we developed relationships 148 
with some mortuary managers, and would visit mortuaries on days when autopsies were not being 149 
conducted to update them on the study’s progress. 150 
Other considerations 151 
Sterile instruments and procedures are not needed if conducting only histological examination of samples; 152 
however, we wished to perform aerobic and mycobacterial culture on samples, but had no access to an 153 
autoclave and encountered difficulties when trying to establish and maintain sterile fields.  Useful items of 154 
equipment, including those used to maintain asepsis in the field, are listed in Table 1.  All waste generated 155 
during MIA should be considered potentially infectious: many private mortuaries do not have procedures for 156 
clinical waste disposal, so we transported waste to a nearby health facility where this could be done safely.  157 
The World Health Organization provides guidance for transporting potentially infectious materials.13   158 
To minimise risk during MIA, staff (four research assistants and a driver, in our study) should be trained in 159 
safe practices; educated about potential risks; and advised of the importance of knowing their own HIV 160 
status. These procedures should, ideally, be embedded within an occupational health programme: all staff 161 
should undergo regular screening for active TB and staff who are HIV positive should be made aware of their 162 
increased risk of TB and encouraged to take antiretroviral therapy.  In addition, at regular intervals during 163 
the study, we organised debriefing sessions, led by a psychologist, to discuss issues arising from conducting 164 
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autopsies and dealing with bereaved families, and to provide team members with tools to manage stress 165 
and avoid burnout.   166 
CONCLUSIONS 167 
MIA, used in routine surveillance, could improve estimates of disease burden and cause-specific mortality, 168 
but the barriers to effective deployment should not be underestimated.  If autopsies are to be more widely 169 
conducted outside of hospitals, health professionals and research organisations will need to engage 170 
wholeheartedly with the communities in which they work and strive to understand local beliefs and 171 
practices around death.  Thorough preparation, education, transparency, respect, trust, and partnership 172 
with communities will be central to this process. 173 
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TABLES 223 
Table 1. Suggested essential equipment for conducting an MIA in the field 224 
Category / sub-category / item/s Comments 
Documentation Approvals from research ethics committee/s and national, provincial, and 
district department of health 
All documentation that 
is handed to families or 
mortuary staff should 
be approved by 
oversight bodies and 
should include study 
team contact details  
Plain-language summary of study aims and activities for families 
Plain-language summary of study aims and activities for mortuary owners 
and staff 
Formal information sheets and consent forms 
Lab request forms 
Personal 
protective 
equipment 
N95 mask Suggested as a 
minimum set per 
person. Appropriate 
training around 
universal precautions 
and disposal of sharps 
should be conducted. 
Goggles, visor, or other eye protection 
Gown/apron 
Non-sterile latex gloves 
Alcohol gel 
Hair net and shoe covers (or rubber boots) 
Autopsy kit Preparatory Headtorch Medium for 
transportation of 
samples should be 
tailored to lab 
requirements. 
Folding work-surface/s 
For cleaning: Povidone iodine; cold sterilant (min 150ml)* 
For samples: Formalin; sterile saline 
Sharps Sharps bin Suggest use of 
disposable equipment 
unless able to access 
sterilising facilities 
(cold sterilant* can be 
used to disinfect) 
Scalpel (small) 
Tissue biopsy needles 
18G hypodermic needles 
Spinal needle/s 
Skin sutures (nylon, 4-0)  
Surgical scissors 
BAL/ CSF/ 
Blood/ 
Urine 
Catheter/s (male and female)†  
Nasogastric tube/s‡ 
Syringes (20ml)  
Sterile lubricating gel (sachets) 
Sterile saline pack/s (200ml)‡ 
Other Sterile gauze; alcohol swabs; surgical forceps; needle-holder; 
plasters 
 
Sterile gloves and sterile procedure kits (if needed) 
Miscellaneous Waste & 
transport 
Waste bags (one for clinical waste, one for general waste) See WHO/IATA 
guidelines for 
requirements around 
transportation and 
labelling of potentially 
infectious specimens 
Paper towels and cleaning fluid 
Bio-bottles 
Ice packs 
Styrofoam insulation container 
Other Clipboard, pens, and permanent marker  
Scissors and adhesive tape 
Spare batteries (for headtorch) 
*Can be used to disinfect (in ~5–10 minutes) or sterilise (in ~15–20 minutes, depending on manufacturer) steel 225 
instruments.  †Required only if collecting urine.  ‡Required only if conducting modified broncho-alveolar lavage 226 
BAL: bronchoalveolar lavage; CSF: cerebrospinal fluid; IATA: International Air Transport Association; MIA: minimally-227 
invasive autopsy; WHO: World Health Organization  228 
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FIGURES 229 
Figure 1. Overview of processes and interactions needed to obtain consent for and conduct MIA in a 230 
private mortuary or other community location 231 
 232 
*Sterile precautions required only if attempting to collect samples for bacteriology (e.g., microscopy or culture) 233 
IATA: International Air Travel Association; MIA: minimally-invasive autopsy; WHO: World Health Organization 234 
